Cargando…

The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation

Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires the conversion of early endo/phagosomes into lysosomes by a process called maturation. Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small molecule inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Baranov, Maksim V., Bianchi, Frans, Schirmacher, Anastasiya, van Aart, Melissa A.C., Maassen, Sjors, Muntjewerff, Elke M., Dingjan, Ilse, ter Beest, Martin, Verdoes, Martijn, Keyser, Samantha G.L., Bertozzi, Carolyn R., Diederichsen, Ulf, van den Bogaart, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319320/
https://www.ncbi.nlm.nih.gov/pubmed/30612035
http://dx.doi.org/10.1016/j.isci.2018.12.015
_version_ 1783385051864498176
author Baranov, Maksim V.
Bianchi, Frans
Schirmacher, Anastasiya
van Aart, Melissa A.C.
Maassen, Sjors
Muntjewerff, Elke M.
Dingjan, Ilse
ter Beest, Martin
Verdoes, Martijn
Keyser, Samantha G.L.
Bertozzi, Carolyn R.
Diederichsen, Ulf
van den Bogaart, Geert
author_facet Baranov, Maksim V.
Bianchi, Frans
Schirmacher, Anastasiya
van Aart, Melissa A.C.
Maassen, Sjors
Muntjewerff, Elke M.
Dingjan, Ilse
ter Beest, Martin
Verdoes, Martijn
Keyser, Samantha G.L.
Bertozzi, Carolyn R.
Diederichsen, Ulf
van den Bogaart, Geert
author_sort Baranov, Maksim V.
collection PubMed
description Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires the conversion of early endo/phagosomes into lysosomes by a process called maturation. Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small molecule inhibitors caused a delay in the conversion of phagosomes into lysosomes and in phagosomal acidification, whereas production of reactive oxygen species (ROS) increased. Elevated ROS resulted in reduced activity of cathepsin S and B, but not X, causing a proteolytic defect of MHC class II chaperone invariant chain Ii processing. We developed a novel universal MHC class II presentation assay based on a bio-orthogonal “clickable” antigen and showed that MHC class II presentation was disrupted by the inhibition of PIKfyve, which in turn resulted in reduced activation of CD4(+) T cells. Our results demonstrate a key role of PIKfyve in the processing and presentation of antigens, which should be taken into consideration when targeting PIKfyve in autoimmune disease and cancer.
format Online
Article
Text
id pubmed-6319320
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63193202019-01-09 The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation Baranov, Maksim V. Bianchi, Frans Schirmacher, Anastasiya van Aart, Melissa A.C. Maassen, Sjors Muntjewerff, Elke M. Dingjan, Ilse ter Beest, Martin Verdoes, Martijn Keyser, Samantha G.L. Bertozzi, Carolyn R. Diederichsen, Ulf van den Bogaart, Geert iScience Article Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires the conversion of early endo/phagosomes into lysosomes by a process called maturation. Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small molecule inhibitors caused a delay in the conversion of phagosomes into lysosomes and in phagosomal acidification, whereas production of reactive oxygen species (ROS) increased. Elevated ROS resulted in reduced activity of cathepsin S and B, but not X, causing a proteolytic defect of MHC class II chaperone invariant chain Ii processing. We developed a novel universal MHC class II presentation assay based on a bio-orthogonal “clickable” antigen and showed that MHC class II presentation was disrupted by the inhibition of PIKfyve, which in turn resulted in reduced activation of CD4(+) T cells. Our results demonstrate a key role of PIKfyve in the processing and presentation of antigens, which should be taken into consideration when targeting PIKfyve in autoimmune disease and cancer. Elsevier 2018-12-20 /pmc/articles/PMC6319320/ /pubmed/30612035 http://dx.doi.org/10.1016/j.isci.2018.12.015 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Baranov, Maksim V.
Bianchi, Frans
Schirmacher, Anastasiya
van Aart, Melissa A.C.
Maassen, Sjors
Muntjewerff, Elke M.
Dingjan, Ilse
ter Beest, Martin
Verdoes, Martijn
Keyser, Samantha G.L.
Bertozzi, Carolyn R.
Diederichsen, Ulf
van den Bogaart, Geert
The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
title The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
title_full The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
title_fullStr The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
title_full_unstemmed The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
title_short The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
title_sort phosphoinositide kinase pikfyve promotes cathepsin-s-mediated major histocompatibility complex class ii antigen presentation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319320/
https://www.ncbi.nlm.nih.gov/pubmed/30612035
http://dx.doi.org/10.1016/j.isci.2018.12.015
work_keys_str_mv AT baranovmaksimv thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT bianchifrans thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT schirmacheranastasiya thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT vanaartmelissaac thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT maassensjors thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT muntjewerffelkem thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT dingjanilse thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT terbeestmartin thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT verdoesmartijn thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT keysersamanthagl thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT bertozzicarolynr thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT diederichsenulf thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT vandenbogaartgeert thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT baranovmaksimv phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT bianchifrans phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT schirmacheranastasiya phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT vanaartmelissaac phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT maassensjors phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT muntjewerffelkem phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT dingjanilse phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT terbeestmartin phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT verdoesmartijn phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT keysersamanthagl phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT bertozzicarolynr phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT diederichsenulf phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation
AT vandenbogaartgeert phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation